RxDoctor Payments Data

Muzammil Mushtaq, MD

Interventional Cardiology · Fort Worth, TXNPI 1093977639

Payments from drug & device makers

$5,187in general payments, 2019–2025

Across 103 payments — averaging $50.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • W. L. Gore & Associates, Inc.$1K
  • Abbott$295
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$246
  • AstraZeneca$242
  • Medtronic$232
  • plus $1K from 23 others

What the payments were for

  • Travel & lodging$2,05940%
  • Food & beverage$3,01758%
  • Education$1112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,187 in reported general payments places this provider in the 25th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas

Medicare billing

Part B allowed, 2024
$18,209
Medicare patients
92
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate55$776
Isosorbide Mononitrate ErIsosorbide Mononitrate35$408
Rosuvastatin Calcium37$395
ClopidogrelClopidogrel Bisulfate24$236
Losartan Potassium14$220
Carvedilol24$155
Amlodipine Besylate22$66
Atorvastatin Calcium16$50
Lisinopril16$47

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →